1. Home
  2. KOPN vs ASMB Comparison

KOPN vs ASMB Comparison

Compare KOPN & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

N/A

Current Price

$3.23

Market Cap

856.9M

Sector

Technology

ML Signal

N/A

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$20.85

Market Cap

512.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOPN
ASMB
Founded
1984
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
856.9M
512.1M
IPO Year
2025
2010

Fundamental Metrics

Financial Performance
Metric
KOPN
ASMB
Price
$3.23
$20.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$8.57
★ $51.20
AVG Volume (30 Days)
★ 3.4M
213.0K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 103.03
91.78
EPS
★ N/A
N/A
Revenue
★ $1,530,311.00
N/A
Revenue This Year
$56.19
N/A
Revenue Next Year
$31.90
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 46.53
N/A
52 Week Low
$1.81
$19.20
52 Week High
$6.61
$39.71

Technical Indicators

Market Signals
Indicator
KOPN
ASMB
Relative Strength Index (RSI) 43.19 46.75
Support Level $2.65 $19.25
Resistance Level $4.39 $21.65
Average True Range (ATR) 0.32 1.23
MACD 0.02 0.32
Stochastic Oscillator 38.62 45.27

Price Performance

Historical Comparison
KOPN
ASMB

About KOPN Kopin Corporation

Kopin Corp is a developer and provider of inventive display, and application-specific optical solutions sold as critical components and subassemblies for defense, enterprise, professional and consumer products. Its portfolio includes micro displays, display modules, eyepiece assemblies, image projection modules, and vehicle mounted and head-mounted display systems that incorporate ultra-small high-resolution Active Matrix Liquid Crystal displays (AMLCD), Ferroelectric Liquid Crystal on Silicon (FLCoS) displays, MicroLED displays (uLED) and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: